324 related articles for article (PubMed ID: 9697880)
21. Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
Richards S; Burrett J; Hann I; Chessells J; Hill F; Bailey C
Leukemia; 1998 Jul; 12(7):1031-6. PubMed ID: 9665186
[TBL] [Abstract][Full Text] [Related]
22. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
Leuk Lymphoma; 2001 Jun; 42(1-2):75-82. PubMed ID: 11699224
[TBL] [Abstract][Full Text] [Related]
23. Childhood acute lymphoblastic leukemia immunophenotypes and their prognostic significance: experience of the IGCI-study in 389 children. International Society for Chemo-immunotherapy (IGCI-Vienna) Cooperative Group.
Holowiecki J; Koehler M; Zintl Z; Kardos G; Lutz D; Krzemien S; Rewesz T; Brugiatelli M; Callea V; Kachel L
Leuk Lymphoma; 1992 Jun; 7(3):225-34. PubMed ID: 1477650
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
25. Determination of myeloid antigen expression on childhood acute lymphoblastic leukaemia cells: discrepancies using different monoclonal antibody clones.
Firat H; Favier R; Adam M; Leverger G; Landman-Parker J; Cayre Y; Douay L
Leuk Lymphoma; 2001 Aug; 42(4):675-82. PubMed ID: 11697497
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.
Eden OB; Harrison G; Richards S; Lilleyman JS; Bailey CC; Chessells JM; Hann IM; Hill FG; Gibson BE
Leukemia; 2000 Dec; 14(12):2307-20. PubMed ID: 11187922
[TBL] [Abstract][Full Text] [Related]
27. Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trial.
Fuhrmann S; Schabath R; Möricke A; Zimmermann M; Kunz JB; Kulozik AE; Ludwig WD; Schrappe M; Karawajew L; Ratei R
Br J Haematol; 2018 Oct; 183(1):96-103. PubMed ID: 30028023
[TBL] [Abstract][Full Text] [Related]
28. Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis.
Preti HA; Huh YO; O'Brien SM; Andreeff M; Pierce ST; Keating M; Kantarjian HM
Cancer; 1995 Nov; 76(9):1564-70. PubMed ID: 8635059
[TBL] [Abstract][Full Text] [Related]
29. Acute lymphoblastic leukaemia in adults: immunological subtypes and clinical features at presentation.
van't Veer MB; van Putten WL; Verdonck LF; Ossenkoppele GJ; Löwenberg B; Kluin-Nelemans JC; Wijermans PW; Schouten HC; Sizoo W; Dekker AW
Ann Hematol; 1993 Jun; 66(6):277-82. PubMed ID: 7686403
[TBL] [Abstract][Full Text] [Related]
30. Early T-cell precursor acute lymphoblastic leukaemia in children treated in AIEOP centres with AIEOP-BFM protocols: a retrospective analysis.
Conter V; Valsecchi MG; Buldini B; Parasole R; Locatelli F; Colombini A; Rizzari C; Putti MC; Barisone E; Lo Nigro L; Santoro N; Ziino O; Pession A; Testi AM; Micalizzi C; Casale F; Pierani P; Cesaro S; Cellini M; Silvestri D; Cazzaniga G; Biondi A; Basso G
Lancet Haematol; 2016 Feb; 3(2):e80-6. PubMed ID: 26853647
[TBL] [Abstract][Full Text] [Related]
31. Periodic acid Schiff reaction in childhood lymphoblastic leukaemia. The Medical Research Council Working Party on Childhood Leukaemia.
Lilleyman JS; Britton JA; Anderson LM; Richards SM; Bailey CC; Chessells JM
J Clin Pathol; 1994 Aug; 47(8):689-92. PubMed ID: 7962616
[TBL] [Abstract][Full Text] [Related]
32. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative.
Pui CH; Raimondi SC; Hancock ML; Rivera GK; Ribeiro RC; Mahmoud HH; Sandlund JT; Crist WM; Behm FG
J Clin Oncol; 1994 Dec; 12(12):2601-6. PubMed ID: 7989935
[TBL] [Abstract][Full Text] [Related]
33. Outcomes and prognostic factors of Chinese children with acute lymphoblastic leukemia in Hong Kong: preliminary results.
Shing MM; Li CK; Chik KW; Lam TK; Lai HD; Ng MH; Cheung AY; Yuen PM
Med Pediatr Oncol; 1999 Feb; 32(2):117-23. PubMed ID: 9950200
[TBL] [Abstract][Full Text] [Related]
34. PreB1 (CD10-) acute lymphoblastic leukemia: immunophenotypic and genomic characteristics, clinical features and outcome in 38 adults and 26 children. The Groupe dEtude Immunologique des Leucémies.
Lenormand B; Béné MC; Lesesve JF; Bastard C; Tilly H; Lefranc MP; Faure GC; Garand R; Falkenrodt A; Kandel G; Solary E; Maynadié M; Callat MP; Thouret F; Monconduit M; Vannier JP
Leuk Lymphoma; 1998 Jan; 28(3-4):329-42. PubMed ID: 9517504
[TBL] [Abstract][Full Text] [Related]
35. [Characteristics of T-cell lineage immunophenotype in 95 patients with acute lymphoid leukemia].
Yuan TT; Liu YR; Chang Y; Hao L; Wang YZ; Jiang B; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Oct; 19(5):1134-40. PubMed ID: 22040958
[TBL] [Abstract][Full Text] [Related]
36. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia.
Kurec AS; Belair P; Stefanu C; Barrett DM; Dubowy RL; Davey FR
Cancer; 1991 Jun; 67(12):3081-6. PubMed ID: 2044051
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications.
Lauria F; Raspadori D; Martinelli G; Rondelli D; Ventura MA; Farabegoli P; Tosi P; Testoni N; Visani G; Zaccaria A
Br J Haematol; 1994 Jun; 87(2):286-92. PubMed ID: 7947269
[TBL] [Abstract][Full Text] [Related]
38. The immunophenotype in infant acute lymphoblastic leukaemia: correlation with clinical outcome. An Italian multicentre study (AIEOP).
Basso G; Putti MC; Cantú-Rajnoldi A; Saitta M; Santostasi T; Santoro N; Lippi A; Comelli A; Felici L; Favre C
Br J Haematol; 1992 Jun; 81(2):184-91. PubMed ID: 1643015
[TBL] [Abstract][Full Text] [Related]
39. Blast cell vacuoles in childhood lymphoblastic leukaemia.
Lilleyman JS; Hann IM; Stevens RF; Richards SM; Eden OB
Br J Haematol; 1988 Oct; 70(2):183-6. PubMed ID: 3191029
[TBL] [Abstract][Full Text] [Related]
40. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
